Products
Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Vitamin B12 test kit

Dirlotapide

Cat. No.: 0225LY-1238
Appearance: Solid
Purity: ≥99%
Identity: Confirmed by NMR, and LC-MS.
Size:
Dirlotapide
Add to basket

Product Overview

Description: Dirlotapide is a selective MTP inhibitor for the intestine that promotes weight loss, potentially by stimulating the release of peptide YY and reducing food intake.
Synonym: CP742033; Slentrol; 481658-94-0; CP-742,033; CP 742033; CP-742033; 1H-Indole-2-carboxamide, 1-methyl-N-((1S)-2-(methyl(phenylmethyl)amino)-2-oxo-1-phenylethyl)-5-(((4'-(trifluoromethyl)(1,1'-biphenyl)-2-yl)carbonyl)amino)-; 5-((4'-trifluoromethyl-biphenyl-2-carbonyl)-amino)-1H-indole-2-carboxylic acid benzylmethyl carbamoylamide; N-((1S)-2-(Benzylmethylamino)-2-oxo-1-phenylethyl)-1-methyl-5-(((4'-(trifluoromethyl)biphenyl-2-yl)carbonyl)amino)-1H-indole-2-carboxamide; N-[(1S)-2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl]-1-methyl-5-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]indole-2-carboxamide
CAS No.: 481658-94-0
Compound CID: 9917862
Formula: C40H33F3N4O3
Formula Weight: 674.71

Specification

Relative Density: 1.25 g/cm3
Stability: 3 years in powder form.
Storage: Storage at -20°C.
Applications: Dirlotapide can be used in veterinary and metabolic research to examine the regulation of appetite and fat absorption.

Library Information

Target: MTP
Receptor: MTTP
Pathways: Metabolism
Plate Number: AOCL-16
Plate Location: h5
Empty Location: a1-h1; a12-h12
Container: 96-well plate
Formulation: 10mM DMSO
DMSO Max Solubility: 262.5 mg/mL; 389.06 mM
Water Max Solubility: <1 mg/mL (insoluble)
Inquiry
0
Inquiry Basket

Copyright © Protheragen. All rights reserves.